Fertility Startup Kindbody Seeks to Raise $50 Million, Cuts Sales Outlook
- Kindbody cuts 2023 forecast to $186 million from $240 million
- The fertility startup has struggled to stem operating losses
Medical equipment in a woman's health clinic in San Antonio, Texas.
Photographer: Matthew Busch/BloombergThis article is for subscribers only.
Fertility startup Kindbody is seeking to raise an additional $50 million to help the company weather larger-than-expected operating losses and a cash burn that it has described to investors as “material.”
The New York-based startup is looking to raise the funds by the end of the year, according to documents and people familiar with the plans who asked not to be identified because the information isn’t public. The company may be valued at $1.8 billion, the people said — the same valuation it got earlier this year in a fundraising round that founder Gina Bartasi told Axios would be its last.